Transaction · 0001022079-26-000021

Davis J. E.

Davis J. E., CEO, PRES, reported an open-market or private sale at QUEST DIAGNOSTICS INC involving 10000.000000 shares for an estimated $2125200.00. Reported holdings after the transaction were 117185.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO, PRES
DGXQUEST DIAGNOSTICS INC
Filing timeMar 04
Trade dateMar 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$208.45
Pre-filing
1mo ago -10.3%1w ago -0.5%1d ago +1.7%
Returns since
7d -3.8%30d -5.0%90d -7.3%180d +17.3%1y +17.3%

DGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
DGX since 2026-03-04Filed 184 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001022079-26-000021
Common Stock
Transaction date
Mar 02, 2026
Filed Mar 04, 2026, 12:00 AM · 2d delay
Shares
10.0k sh
$21.2k per share
Estimated value
-$212M
Computed from shares × price
Holdings after
117k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and President

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

  2. F2

    This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Original filing · 0001022079-26-000021
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

DGX